Storage and Handling for Lyophilized Research Peptides
Material is characterised at release. Whether it still matches that characterisation at the bench depends entirely on storage and handling in between.
Temperature
Lyophilised peptides are generally stable for extended periods refrigerated, and longer at freezer temperatures, with lower temperatures preferred for long-term holding. Reaction rates fall substantially with each reduction in temperature, so the benefit of colder storage is chemical rather than nominal. Ambient shipping excursions are usually tolerable for dry solids over short intervals, but repeated or prolonged warm exposure is not.
Condensation and equilibration
The most common avoidable handling error is opening a cold vial directly. Cold surfaces condense atmospheric moisture immediately, introducing water into a hygroscopic solid that was deliberately dried. Vials should be allowed to equilibrate to room temperature, fully and while still sealed, before the closure is broken.
Light, air, and container integrity
Light accelerates oxidation of susceptible residues, so material is best kept in its original protective packaging. Container closure integrity matters for the same reason: a compromised seal admits both moisture and oxygen. Desiccated secondary storage adds a margin of protection in humid environments.
Aliquoting and freeze-thaw
Where material is placed into solution for laboratory work, repeated freeze-thaw cycling is a known stressor. Freezing concentrates solutes and can shift local pH at the ice interface, and each cycle repeats that stress. Preparing single-use aliquots at the outset avoids subjecting an entire stock to conditions it only needs to experience once.
Record keeping
Storage conditions and dates belong in the experimental record with the lot number. If a result later looks anomalous, handling history is often where the explanation is found.
References
- Manning MC, Chou DK, Murphy BM, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544–575. doi:10.1007/s11095-009-0045-6
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1–2):1–60. doi:10.1016/S0378-5173(00)00423-3
Disclosure. This article is educational and summarises published scientific literature. It is not medical advice, and it does not describe outcomes you should expect. These statements have not been evaluated by the Food and Drug Administration, and the products discussed are not intended to diagnose, treat, cure, or prevent any disease. The products discussed are supplied for laboratory and research use only and are not for human or veterinary use, administration, or consumption. For adults 21 and over.
